No matter what sort of challenge a caregiver may be facing -- financial, emotional, or just trying to find the right resources at the right time, every caregiver challenge is made more difficult by that accompanying feeling of isolation that so many caregivers experience.

My guest is Heidi Telschow, manager of Fairview Health Services' Caregiver Assurance program, a unique program designed to seamlessly connect caregivers to the resources they need.

We're also talking about the eye-popping increase in the prevalence of MS in the United States, now reaching nearly one million adults. We'll tell you about a study that shows how the early use of more intensive MS disease-modifying therapy may provide better outcomes for people living with MS, you'll hear about an Innovation Challenge that could reward your inner entrepreneur with $25,000 in cash, and we'll tell you why the FDA has been asked to fast-track a cannabis-based treatment for spasticity in progressive MS. We have a lot to talk about! Are you ready for RealTalk MS?! ___________

STUDY: MS Prevalence In the United States Nears 1 Million 2:18

STUDY: Long-Term Benefit Seen in Early Use of More Intensive Disease-Modifying Therapy 5:42

Lyfebulb-Celgene Innovation Challenge in MS 9:04

FDA Requested to Fast-Track Cannabis-Based Treatment for Spasticity in Progressive MS 10:43

My Interview with Heidi Telschow from Caregiver Assurance 12:36

___________

ADD YOUR VOICE TO THE CONVERSATION

I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes.

Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!

Email: [email protected]Phone: (310) 526-2283

___________

LINKSIf your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com

Download the RealTalk MS App for iOS

Download the RealTalk MS App for Android

A New Way to Estimate Neurologic Disease Prevalence in the United States Illustrated with Multiple Sclerosis

Validation of an Algorithm for Identifying MS Cases in Administrative Health Claims Datasets

The Prevalence of Multiple Sclerosis in the United States: A Population-Based Estimate Using Health Claims Data

RealTalk MS Episode 74: Induction vs Escalation Therapy with Dr. Aaron Boster

Clinical Outcomes of Escalation vs Early Intensive Disease-Modifying Therapy in Patients With Multiple Sclerosis

Application for Lyfebulb-Celgene Innovation Challenge in MS

Give RealTalk MS a Rating & Review

___________

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 79 Hosted By: Jon Strum Guest: Heidi Telschow

Tags: MS, MultipleSclerosis, MSResearch, TwiceAsMany, Lyfebulb, Caregiving, RealTalkMS